NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE884.5022.5 (+2.61 %)
PREV CLOSE ( ) 862.00
OPEN PRICE ( ) 850.00
BID PRICE (QTY) 875.05 (1)
OFFER PRICE (QTY) 884.50 (3)
VOLUME 380
TODAY'S LOW / HIGH ( )850.00 895.00
52 WK LOW / HIGH ( ) 535.11303
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-02 1982
Management Info
Divyakant R Zaveri - Chairman Rajendra R Shah - Managing Director
Registered Office

Address 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street,
Mumbai,
Maharashtra-400002

Phone 022 - 22015441

Email mllbom@mtnl.net.in / mllbrd@mercurylabs.com / secretarial@mercurylabs.com

Website www.mercurylabs.com

Registrars Details
Link Intime India Pvt Ltd.
Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara
 Listing : BSE, OTCEI
NEWS
11Jan Mercury Laboratories informs about los
In compliance with Regulation 39(3) of the Securities and Exchange Board..
06Jan Mercury Laboratories informs about com
Mercury Laboratories has enclosed certificate received by company’s Regi..
26Sep Mercury Laboratories informs about clo
Pursuant to Securities and Exchange Board of India (Prohibition of Insid..
20Sep Mercury Laboratories informs about los
In compliance with Regulation 39(3) of the Securities and Exchange Board..
02Sep Mercury Laboratories informs about new
Mercury Laboratories has informed that it enclosed newspaper cuttings fo..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit12.3655.79
Gross Profit 15.85 74.93
Operating Profit 24.05102.9
Net Sales 171.15753.34
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Glaxosmithkline Phar (BSE)
 2029.90 (4.49%)
M.Cap (Rs. in Cr)34485.99
Sanofi India (BSE)
 8223.65 (0.99%)
M.Cap (Rs. in Cr)18858.39
Astrazeneca Pharma I (BSE)
 5308.00 (1.06%)
M.Cap (Rs. in Cr)13244.88
Hester Biosciences (BSE)
 1699.00 (2.82%)
M.Cap (Rs. in Cr)1425.84
Alkem Laboratories (BSE)
 4737.75 (0.79%)
M.Cap (Rs. in Cr)56566.80
MORE
Shareholding Pattern
PROMOTERS 73.66%
NON-INSTITUTION 26.34%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.